3-hydroxyflavone has been researched along with Pancreatic Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Li, X; Liu, Y; Shi, C; Sun, L; Wang, C; Weng, M; Xiao, Y | 1 |
| Cao, L; Ding, G; Huang, C; Jia, S; Jin, Y; Pang, T; Xu, G; Zhang, C; Zhou, L; Zhou, S | 1 |
| Cao, L; Chen, Y; Ding, G; Jia, S; Li, D; Ping, D; Wang, W; Xu, X | 1 |
| Kang, MJ; Kim, N; Kim, YT; Lee, JE; Lee, SH; Paik, WH; Ryu, JK; Son, JH | 1 |
| Cao, L; Chen, Y; Ding, G; Jia, S; Xu, X; Zhou, S | 1 |
| Abdel Halim Hegazy, W; Youns, M | 1 |
| Boeing, H; Bueno-de-Mesquita, HB; Clavel-Chapelon, F; Jenab, M; Kolonel, LN; Michaud, DS; Murphy, SP; Nöthlings, U; Roddam, A; Rodriguez, L; Rohrmann, S; Schulze, MB; Sieri, S; Tjønneland, A; Trichopoulou, A; Wilkens, LR; Ye, W | 1 |
| Adhami, VM; Hafeez, BB; Mukhtar, H; Murtaza, I; Saleem, M | 1 |
| Henderson, BE; Kolonel, LN; Murphy, SP; Nöthlings, U; Wilkens, LR | 1 |
9 other study(ies) available for 3-hydroxyflavone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Flavonols; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer.
Topics: Adenosine; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Flavonols; Homeodomain Proteins; Humans; Neoplasm Proteins; Nuclear Proteins; Pancreatic Neoplasms; Rad51 Recombinase; Recombinational DNA Repair; RNA-Binding Proteins; Tumor Suppressor p53-Binding Protein 1 | 2022 |
Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Demethylation; DNA Damage; Epigenesis, Genetic; Female; Flavonols; Gene Expression Regulation, Neoplastic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Mice; Mice, Nude; Middle Aged; Pancreatic Neoplasms; S Phase; Transcription Factors; Xenograft Model Antitumor Assays | 2020 |
Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Down-Regulation; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Flavonols; Gemcitabine; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc | 2018 |
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways.
Topics: Animals; Autophagy; Endoplasmic Reticulum Stress; Flavonoids; Flavonols; Humans; Mice; Mitochondria; Pancreatic Neoplasms | 2019 |
The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
Topics: Apoptosis; Biomarkers, Tumor; Caspase 3; Caspase 7; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cytochrome P-450 CYP3A; Dinoprostone; DNA Damage; Enzyme Activation; Enzyme Assays; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Signal Transduction | 2017 |
A food pattern that is predictive of flavonol intake and risk of pancreatic cancer.
Topics: Brassica; Case-Control Studies; Cohort Studies; Confidence Intervals; Diet Surveys; Ethnicity; Feeding Behavior; Female; Flavonoids; Flavonols; Follow-Up Studies; Fruit; Humans; Incidence; Kaempferols; Male; Multivariate Analysis; Pancreatic Neoplasms; Predictive Value of Tests; Proportional Hazards Models; Quercetin; Risk; Risk Factors; Smoking; Surveys and Questionnaires; Tea; Wine | 2008 |
Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Flavonoids; Flavonols; Gene Expression Profiling; Humans; I-kappa B Proteins; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; NF-KappaB Inhibitor alpha; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Promoter Regions, Genetic; Receptors, Tumor Necrosis Factor, Member 25; RNA, Small Interfering; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein | 2009 |
Flavonols and pancreatic cancer risk: the multiethnic cohort study.
Topics: Aged; Cohort Studies; Confidence Intervals; Diet Surveys; Ethnicity; Feeding Behavior; Female; Flavonols; Follow-Up Studies; Hawaii; Humans; Incidence; Los Angeles; Male; Middle Aged; Pancreatic Neoplasms; Proportional Hazards Models; Risk; Risk Factors; Surveys and Questionnaires; Vegetables | 2007 |